发明名称 DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE
摘要 Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions such as complex regional pain syndrome.
申请公布号 US2017056427(A1) 申请公布日期 2017.03.02
申请号 US201615352461 申请日期 2016.11.15
申请人 ANTECIP BIOVENTURES II LLC 发明人 Tabuteau Herriot
分类号 A61K31/675;A61K9/00 主分类号 A61K31/675
代理机构 代理人
主权项 1. A method of treating pain associated with complex regional pain syndrome comprising orally administering a dosage form comprising zoledronic acid in an acid form or a salt form to a human being in need thereof, wherein the bioavailability of zoledronic acid in the dosage form is about 1.5% to about 1.8%, as determined when orally administered to a human being who has fasted for eight hours.
地址 New York NY US